Skip to main content
painEvidence: Grade B

Using Your Joovv Solo 3.0 for Neuropathy Treatment

Published: Last updated:

Device-specific protocol for Neuropathy using the Joovv Joovv Solo 3.0 (660/850nm, 128 mW/cm²)

Your Joovv Solo 3.0 Protocol for Neuropathy

Wavelengths

660nm, 850nm

Session Time

2 min

Target Dose

12 J/cm²

Distance

6 inches

Frequency

3-5x/week

Timeline

4-12 weeks

Why Joovv Solo 3.0 for Neuropathy?

The Joovv Joovv Solo 3.0 emits at 660nm and 850nm, which provides a good match for Neuropathy treatment. Research for this condition recommends 830nm, 850nm.

At 128 mW/cm² irradiance (at the recommended distance of 6 inches), you'll need approximately 2 minutes per session to reach the target dose of 12 J/cm². This falls within the recommended range of 4-20 J/cm² for Neuropathy.

The Joovv Solo 3.0's half body coverage area makes it suitable for treating larger treatment zones. For Neuropathy, position the device at 6 inches from the target area.

Joovv Solo 3.0 Quick Specs

Price

$1,495

LEDs

150

Power

200W

FDA

Registered

Evidence for Neuropathy

Near-infrared therapy at 830-850nm shows encouraging results for diabetic peripheral neuropathy, with some studies reporting improved sensation and reduced pain scores. Dose: 4-20 J/cm², 15-30 minutes, 3-5x/week for 4-12 weeks. Evidence grade: B (moderate — small but consistent study results).

Same Condition, Different Devices

Research Basis

This content is informed by 47+ published peer-reviewed studies on photobiomodulation.